SHZ · 002219.SZ
New Journey Health Technology Group Co.,LTD
CN¥1.93+CN¥0.04 (+2.12%)
New Journey Health Technology Group Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 35.02% below the high.
Loading market information…
SHZ · 300267.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Hunan Er-Kang Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Hunan Er-Kang Pharmaceutical Co., Ltd’s forward annual dividend is CN¥0.05 per share, paid annual. The forward yield is 1.71% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hunan Er-Kang Pharmaceutical Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥1.93+CN¥0.04 (+2.12%)
New Journey Health Technology Group Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 35.02% below the high.
CN¥2.94+CN¥0.06 (+2.08%)
Harbin Gloria Pharmaceuticals Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.35% below the high.
CN¥13.54+CN¥0.33 (+2.5%)
Chongqing Pharscin Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.69% below the high.
CN¥3.09+CN¥0.18 (+6.19%)
Guizhou Xinbang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.54% below the high.
CN¥26.80+CN¥0.58 (+2.21%)
Jiangsu Jibeier Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.47% below the high.
CN¥21.42-CN¥2.38 (-10.0%)
Shandong Wit Dyne Health Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.76% below the high.
CN¥3.99+CN¥0.05 (+1.27%)
Hainan Haiyao Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.82% below the high.
CN¥4.66-CN¥0.01 (-0.21%)
Shanxi Zhendong Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.87% below the high.
